Karyopharm Therapeutics Inc. Inventory, Finished Goods, Gross
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2026-08-13
- 2026-06-30: Inventory, Finished Goods, Gross $199.00K.
- 2026-03-31: Inventory, Finished Goods, Gross $264.00K.
- 2025-12-31: Inventory, Finished Goods, Gross $430.00K.
- 2025-09-30: Inventory, Finished Goods, Gross $433.00K.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2026-06-30 | $199.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $264.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $430.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $433.00K 10-Q · filed 2025-11-03 |
| 2025-06-30 | $349.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $351.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $477.00K 10-K · filed 2026-02-13 |
| 2024-09-30 | $542.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $598.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $627.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $758.00K 10-K · filed 2025-02-19 |
| 2023-09-30 | $759.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $848.00K 10-Q · filed 2023-08-02 |
| 2023-03-31 | $936.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $976.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $991.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $343.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $385.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $414.00K 10-K · filed 2023-02-17 |
| 2021-09-30 | $398.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $223.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $114.00K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $79.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $445.00K 10-Q · filed 2020-11-02 |
| 2020-06-30 | $302.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $153.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $73.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-04 |